Hormone Therapies and Lung Cancer

Researchers have found a link between female hormone therapies and increased
risks of lung cancer. Post-menopausal women and those going through
menopause generally take hormone's to ease the hot flashes and struggles
associated with menopause.

WebMD said, "New findings from the landmark Women's Health Initiative study
show that women with non-small cell lung cancer are 59% more likely to die
from the disease if they take combined estrogen and progestin. The risk was
particularly high for smokers: There was one avoidable death from non-small
cell lung cancer for every 100 women who both smoked and took hormone
therapy over eight years, the study showed."

Lung cancer has always been considered one of the most fatal cancers,
however doctors have urged high-risk patients (smokers especially) to get
checked via virtual scans regularly with hopes of early detection and
prevention. This may mean that post-menopausal women who took hormone
therapies should also get checked.

---